Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 26, 2020; 8(8): 1463-1470
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1463
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1463
Suicide attempt using potassium tablets for congenital chloride diarrhea: A case report
Shigeo Iijima, Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu 4313192, Japan
Author contributions: Iijima S performed the disease consultation, acquired the clinical data, reviewed the literature, and drafted the manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report.
Conflict-of-interest statement: The author declares no conflicts of interest.
CARE Checklist (2016) statement: The author has read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Shigeo Iijima, MD, PhD, Associate Professor, Department of Regional Neonatal-Perinatal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 4313192, Shizuoka, Japan. sige_pd@yahoo.co.jp
Received: December 17, 2019
Peer-review started: December 17, 2019
First decision: February 26, 2020
Revised: March 2, 2020
Accepted: April 10, 2020
Article in press: April 10, 2020
Published online: April 26, 2020
Peer-review started: December 17, 2019
First decision: February 26, 2020
Revised: March 2, 2020
Accepted: April 10, 2020
Article in press: April 10, 2020
Published online: April 26, 2020
Core Tip
Core tip: The main treatment for congenital chloride diarrhea (CCD) is life-long substitution therapy using sodium chloride and potassium chloride. An oral potassium supplement overdose is rare but can cause life-threatening hyperkalemia in cases of intentional high-dosage ingestion. We encountered an adult patient with CCD who developed hyperkalemia due to self-poisoning of prescribed potassium chloride tablets. In patients with CCD, physicians need to consider extraintestinal issues that patients can encounter as they get older, along with the challenges they face concerning life-long diarrhea. It is especially important to be aware of any potential psychiatric disorders that may cause life-threatening sequelae.